Article: Elidel[R] holds promise in treating infants with eczema.(New Products)(Brief Article)

Newly published data suggest that Elidel[R] (pimecrolimus) Cream 1% is a safe and effective treatment for eczema (atopic dermatitis) in infants, according to a report in the February issue of the Journal of Pediatrics. The study found that after 6 weeks of treatment, more than twice as many patients treated with Elidel were clear or almost clear of eczema, compared with those treated with the vehicle (Elidel cream base without the active ingredient). The authors concluded that Elidel holds promise as a valuable potential treatment option for the youngest patients.

According to the report, approximately 10% to 15% of children under age 5 in developed countries ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!